Zobrazeno 1 - 10
of 10
pro vyhledávání: '"E E Anomneze"'
Publikováno v:
Nigerian Journal of Clinical Practice; Vol 20, No 2 (2017); 188-193
Background: Infection with Helicobacter pylori infection is widespread in our environment. However, whether this fact has any bearing on the prevalence and pattern of symptoms referable to the upper gastrointestinal (GI) system in our population of d
Autor:
Alexander Crispin, Gabriele Rieder, Muinah A Fowora, Ute Harrison, Isaac Adeyemi Adeleye, Fatimah B. Abdulkareem, E. E. Anomneze, Jesse A. Otegbayo, Olusegun Adekanle, Stella I. Smith, Dennis A Ndububa, Eva Loell, Abiodun T. Seriki, Rainer Haas, Adegboyega Akere, Charles A Onyekwere, Margaret Ugo-Ijeh, Susanna Mueller, Wolfgang Fischer, Olufunmilayo A. Lesi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0176454 (2017)
PLoS ONE, Vol 12, Iss 5, p e0176454 (2017)
Antibiotic resistance in Helicobacter pylori is a factor preventing its successful eradication. Particularly in developing countries, resistance against commonly used antibiotics is widespread. Here, we present an epidemiological study from Nigeria w
Autor:
S. Miehlke, CE Atimomo, E. E. Anomneze, E. Bayerdöffer, Agbakwuru Ae, Chibututu Cc, Stella I. Smith, D. A. Ndububa, O A Atoyebi
Publikováno v:
British Journal of Biomedical Science. 60:170-172
Publikováno v:
BMC Research Notes, Vol 5, Iss 1, p 284 (2012)
BMC Research Notes
BMC Research Notes
Background There appears to exist a potentially important interplay between diabetes mellitus (DM) and Helicobacter pylori (H. pylori) infection. Findings from previous studies have been conflicting. Only a few studies have examined the topic in a su
Publikováno v:
Nigerian Quarterly Journal of Hospital Medicine; Vol 12, No 1 (2002); 1-5
Objectives: This case-control study sets out to investigate the prevalence of antibodies to hepatitis C virus (anti-HCV) and its association with the presence of hepatitis B surface antigen (HBsAg) in Nigerians with chronic liver disease. Method: Sev
Autor:
S I, Smith, K S, Oyedeji, A O, Arigbabu, C C, Chibututu, E E, Anomneze, A E, Agbakwuru, D A, Ndububa, A O, Coker
Publikováno v:
British journal of biomedical science. 58(2)
Publikováno v:
West African journal of medicine. 19(4)
The efficacy and safety of recombinant interferon alfa-2a (rIFN) was evaluated in 26 adult Nigerian patients with chronic hepatitis B infection. Male and female patients with serological evidence of HBV infection (HBsAg and/or HBeAg positive patients
Autor:
Oluyemi A; Gastroenterology Unit, ReMay Consultancy and Medical Services, Ikeja, Lagos, Nigeria., Anomneze E; Gastroenterology Unit, Health Gates Consultancy and Medical Services, Maryland, Lagos, Nigeria., Smith S; Division of Molecular Biology, Nigerian Institute of Medical Research, Lagos, Nigeria., Fasanmade O; Endocrinology Unit, College of Medicine, University of Lagos, Lagos, Nigeria.
Publikováno v:
Nigerian journal of clinical practice [Niger J Clin Pract] 2017 Feb; Vol. 20 (2), pp. 188-193.
Autor:
Smith SI; Molecular Biology and Biotechnology Division, Nigerian Institute of Medical Research, PMB 2013, Yaba, Logos, Nigeria. stellaismith@yahoo.com, Oyedeji KS, Goodluck HA, Fowora MA, Anomneze E, Lesi OA
Publikováno v:
The West Indian medical journal [West Indian Med J] 2011 Jan; Vol. 60 (1), pp. 33-5.
Autor:
Smith SI; Molecular Biology and Biotechnology Division, Nigerian Institute of Medical Research, P.M.B. 2013, Yaba, Lagos, Nigeria. stellaismith@yahoo.com, Chibututu C, Anomneze E, Atimomo C, Atoyebi O, Ndububa D, Agbakwuru A, Bayerdöffer E, Miehlke S
Publikováno v:
British journal of biomedical science [Br J Biomed Sci] 2003; Vol. 60 (3), pp. 170-2.